Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	301.78	262.65	224.92	198.45	172.73
Revenue Growth (YoY)	14.90%	16.77%	13.34%	14.89%	40.86%
Cost of Revenue	153.93	133.18	115.1	96.55	84.05
Gross Profit	147.85	129.47	109.83	101.9	88.68
Selling, General & Admin	67.26	56.6	45.4	45.07	36.32
Depreciation & Amortization Expenses	23.9	20.88	16.98	15	14.09
Other Operating Expenses	-3.85	-3.69	-2.57	0.34	-1.16
Total Operating Expenses	87.31	73.8	59.81	60.4	49.25
Operating Income	60.54	55.67	50.01	41.49	39.43
Interest Income	1.52	0.3	0.15	0.07	0
Interest Expense	-2.28	-1.22	-0.57	-0.42	-0.46
Other Non-Operating Income (Expense)	0.33	1.24	0.06	-0.46	-0.08
Total Non-Operating Income (Expense)	-0.43	0.32	-0.36	-0.81	-0.53
Pretax Income	60.11	55.99	49.65	40.68	38.9
Provision for Income Taxes	17.18	14.86	12.92	10.53	10.97
Net Income	42.94	41.14	36.73	30.15	27.93
Minority Interest in Earnings	0.87	0.93	0.76	0.63	0.54
Net Income to Common	42.06	40.21	35.97	29.52	27.39
Net Income Growth	4.62%	11.77%	21.86%	7.77%	96.46%
Shares Outstanding (Basic)	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16
Shares Change (YoY)	0.08%	-1.85%	-	-	0.01%
EPS (Basic)	2.58	2.47	2.21	1.81	1.68
EPS (Diluted)	2.58	2.47	2.21	1.81	1.68
EPS Growth	4.45%	11.77%	22.10%	7.74%	97.65%
Free Cash Flow	46.47	36	35.13	39.41	36.33
Free Cash Flow Growth	29.10%	2.47%	-10.86%	8.48%	53.71%
Free Cash Flow Per Share	2.90	2.25	2.15	2.42	2.23
Dividends Per Share	1.570	1.570	1.570	1.300	1.030
Dividend Growth	-	-	20.77%	26.21%	86.59%
Gross Margin	48.99%	49.29%	48.83%	51.35%	51.34%
Operating Margin	20.06%	21.20%	22.24%	20.91%	22.83%
Profit Margin	14.23%	15.66%	16.33%	15.19%	16.17%
FCF Margin	15.40%	13.71%	15.62%	19.86%	21.03%
EBITDA	84.44	76.55	67	56.49	53.52
EBITDA Margin	27.98%	29.15%	29.79%	28.47%	30.99%
EBIT	60.54	55.67	50.01	41.49	39.43
EBIT Margin	20.06%	21.20%	22.24%	20.91%	22.83%
Effective Tax Rate	28.57%	26.53%	26.02%	25.89%	28.20%